胺碘酮复律阵发性心房颤动42例临床观察

Clinical observation of 42 cases of amiodarone cardioerter paroxysmal a-trial fibrillation

目的观察胺碘酮对阵发性心房颤动复律的临床疗效。方法选择我心血管内科阵发性心房颤动患者84例,随机分为胺碘酮组(42例)、西地兰组(42例)。实验组患者采用胺碘酮转复阵发性心房颤动,对照组患者采用西地兰转复阵发性心房颤动。比较两组患者的临床疗效和转复后心率。结果胺碘酮组转复阵发性心房颤动总有效率85.7%,西地兰组转复阵发性心房颤动总有效率36.6%,两组比较差异有统计学意义(P<0.01);两组复律后心率无显著差异。结论胺碘酮可有效转复阵发性心房颤动,疗效肯定。

Objective To observe the clinical efficacy of amiodarone in cardioversion of paroxysmal atrial fibrillation. Methods The cardiovascular department of internal medicine 84 cases of patients with paroxysmal atrial fibrillation were chosen. They were randomly divided into the amiodaronr group （42 cases） and the cedilanid group （42 cases）. The experimental group was treated with amiodarone for paroxysmal atrial fibrillation, the control group was treated with cedilanid for paroxysmal atrial fibri[[ation. The clinical efficacy of two groups of patients and the after converting the heart rate were compared with each other. Results The total effectively of amidarone in conversion of paroxysmal atrial fibrillation group was 85.7%. Cedilanid group cardioversion of paroxysmal atrial fibrillation total efficiency was 36.6%. There was statistically significant between the two groups （P〈0.01）. There was no significant difference between the two groups after cardioversion rate. Conclusion Amiodarone may be effective for cardioversion of paroxysmal atrial fibrillation.